Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Biotech Industry Analysis

UpdatedApr 03, 2026
DataAggregated Company Financials
Companies70
  • 7D-0.7%
  • 3M6.6%
  • 1Y12.2%
  • YTDn/a

Last week, the Biotech industry hasn't moved much but Medigen Vaccine Biologics is up 13% in that time. The past year has been better, since the industry has gained 12% in that time. Looking forward, earnings are forecast to grow by 56% annually.

Industry Valuation and Performance

Has the Taiwanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 04 Apr 2026NT$630.0bNT$34.3b-NT$10,990,785,500.0028.8x-57.3x18.3x
Mon, 02 Mar 2026NT$696.9bNT$33.4b-NT$8,941,108,500.0029.5x-77.9x20.9x
Wed, 28 Jan 2026NT$685.4bNT$33.4b-NT$7,105,005,000.0029.7x-96.5x20.5x
Fri, 26 Dec 2025NT$567.9bNT$33.4b-NT$6,808,544,000.0029.6x-83.4x17x
Sun, 23 Nov 2025NT$516.1bNT$33.0b-NT$7,467,266,000.0036x-69.1x15.6x
Tue, 21 Oct 2025NT$553.0bNT$32.2b-NT$8,364,979,000.0035.6x-66.1x17.2x
Thu, 18 Sep 2025NT$538.2bNT$32.2b-NT$8,650,248,000.0034.9x-62.2x16.7x
Sat, 16 Aug 2025NT$517.6bNT$32.3b-NT$7,826,502,000.0034x-66.1x16x
Mon, 14 Jul 2025NT$504.4bNT$30.2b-NT$6,412,141,000.0036.6x-78.7x16.7x
Wed, 11 Jun 2025NT$508.9bNT$30.2b-NT$6,460,452,000.0038.1x-78.8x16.8x
Fri, 09 May 2025NT$497.6bNT$28.6b-NT$7,301,427,000.0036.9x-68.2x17.4x
Sun, 06 Apr 2025NT$504.0bNT$28.1b-NT$7,302,014,000.0031.3x-69x17.9x
Tue, 04 Mar 2025NT$559.3bNT$27.9b-NT$8,450,830,000.0032.7x-66.2x20.1x
Thu, 30 Jan 2025NT$550.6bNT$24.8b-NT$10,902,841,000.0034.9x-50.5x22.2x
Sat, 28 Dec 2024NT$512.6bNT$24.8b-NT$10,902,841,000.0034.3x-47x20.7x
Mon, 25 Nov 2024NT$509.1bNT$24.8b-NT$10,782,551,000.0037.6x-47.2x20.6x
Wed, 23 Oct 2024NT$538.8bNT$23.5b-NT$10,829,095,000.0034.7x-49.8x22.9x
Fri, 20 Sep 2024NT$575.9bNT$23.5b-NT$10,829,095,000.0034.4x-53.2x24.5x
Sun, 18 Aug 2024NT$560.6bNT$23.5b-NT$10,722,450,000.0033.9x-52.3x23.8x
Tue, 16 Jul 2024NT$565.6bNT$21.9b-NT$11,110,643,000.0044.9x-50.9x25.8x
Thu, 13 Jun 2024NT$515.2bNT$21.9b-NT$11,110,643,000.0042.6x-46.4x23.5x
Sat, 11 May 2024NT$456.4bNT$21.6b-NT$12,518,170,000.0049.4x-36.5x21.2x
Mon, 08 Apr 2024NT$442.7bNT$21.0b-NT$10,766,949,000.0051.8x-41.1x21x
Wed, 06 Mar 2024NT$444.7bNT$20.7b-NT$9,901,890,000.0039.1x-44.9x21.5x
Fri, 02 Feb 2024NT$436.4bNT$19.9b-NT$9,830,596,000.0039.2x-44.4x21.9x
Sun, 31 Dec 2023NT$472.2bNT$19.8b-NT$9,748,146,000.0039.5x-48.4x23.9x
Tue, 28 Nov 2023NT$481.7bNT$19.9b-NT$9,817,316,000.0043x-49.1x24.2x
Thu, 26 Oct 2023NT$462.8bNT$18.4b-NT$10,823,013,000.0049.5x-42.8x25.1x
Sat, 23 Sep 2023NT$480.2bNT$18.3b-NT$10,776,417,000.0042.6x-44.6x26.2x
Mon, 21 Aug 2023NT$475.2bNT$18.2b-NT$10,711,380,000.0041.9x-44.4x26.1x
Wed, 19 Jul 2023NT$474.4bNT$18.7b-NT$10,724,655,000.0044.6x-44.2x25.4x
Fri, 16 Jun 2023NT$478.4bNT$18.7b-NT$10,709,428,000.0043.1x-44.7x25.6x
Sun, 14 May 2023NT$493.1bNT$18.5b-NT$9,923,222,000.0045.3x-49.7x26.6x
Tue, 11 Apr 2023NT$507.2bNT$18.5b-NT$9,562,796,000.0042.7x-53x27.4x
Price to Earnings Ratio

-53x


Total Market Cap: NT$507.2bTotal Earnings: -NT$9,562,796,000.00Total Revenue: NT$18.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Biotech Industry Price to Earnings3Y Average -56.2x202420252026
Current Industry PE
  • Investors are pessimistic on the Taiwanese Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 21.5x is higher than the industry's current PS ratio of 18.3x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 23% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Taiwanese Biotech compare with similar industries?

TW Market-2.24%
Healthcare0.20%
Biotech-0.71%
Biotech-0.71%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6547 Medigen Vaccine BiologicsNT$58.806.7%
+NT$1.2b		21.6%PS31.5x
4169 TCM Biotech InternationalNT$176.5010.0%
+NT$944.8m		213.5%PE543.7x
4147 TaiMed BiologicsNT$57.104.8%
+NT$710.3m		-35.0%PS25.5x
6976 AcepodiaNT$12.659.1%
+NT$613.1m		-31.1%PS39811.2x
6550 Polaris GroupNT$19.901.5%
+NT$258.0m		-44.9%PS421.5x

Latest News

6945
NT$201.50
AP Biosciences
7D
-2.4%
1Y
289.0%
4169
NT$176.50
TCM Biotech International
7D
10.0%
1Y
213.5%
6976
NT$12.65
Acepodia
7D
9.1%
1Y
-31.1%
7827
NT$126.50
HanchorBio
7D
-2.7%
1Y
n/a
4147
NT$57.10
TaiMed Biologics
7D
4.8%
1Y
-35.0%
4728
NT$384.50
Sunmax Biotechnology
7D
-1.2%
1Y
0.5%
6547
NT$58.80
Medigen Vaccine Biologics
7D
6.7%
1Y
21.6%
6492
NT$48.90
Senhwa Biosciences
7D
-10.3%
1Y
25.5%
7888
NT$46.80
Libo Pharma
7D
4.8%
1Y
n/a
6550
NT$19.90
Polaris Group
7D
1.5%
1Y
-44.9%
4142
NT$18.90
Adimmune
7D
2.2%
1Y
-7.4%
6949
NT$562.00
Pell Bio-Med Technology
7D
-0.9%
1Y
297.2%
7871
NT$70.20
Elixiron Immunotherapeutics (Cayman)
7D
-2.6%
1Y
n/a
6446
NT$632.00
PharmaEssentia
7D
-1.3%
1Y
30.8%
7902
NT$38.75
Uwell Biopharma
7D
-3.4%
1Y
n/a
6696
NT$386.50
Lin BioScience
7D
0.5%
1Y
189.5%